Fereshteh Ghadiri, Mohammad Ali Sahraian, Nazanin Razazian, Fereshteh Ashtari, Maryam Poursadeghfard, Seyed Massood Nabavi, Samira Navardi, Seyed Mohammad Baghbanian, Vahid Shaygannejad, Mohammad Hossein Harirchian, Nahid Beladimoghadam, Nastaran Majdinasab, Samaneh Hosseini, Amirreza Azimi, Hoda Kamali, Ehsan Sharifipour, Nahid Hosseini Nejad Mir, Asghar Bayati, Mohammad Ali Nahayati, Hora Heidari, Hossein Mozhdehipanah, Hamidreza Ghalyanchi Langroodi, Nazanin Jalali, Saeideh Ayoubi, Elnaz Asadollahzadeh, Zahra Ebadi, Sharareh Eskandarieh, Abdorreza Naser Moghadasi
BACKGROUND: Today, it is estimated that around 5% of multiple sclerosis (MS) patients are in the late-onset category (age at disease onset ≥ 50). Diagnosis and treatment in this group could be challenging. Here, we report the latest update on the characteristics of Iranian patients with late-onset MS (LOMS). METHODS: This cross-sectional study used the information provided by the nationwide MS registry of Iran (NMSRI). The registrars from 14 provinces entered data of patients with a confirmed diagnosis of MS by neurologists...
December 29, 2022: Multiple Sclerosis and related Disorders